Beryl Drugs

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue5.645.405.224.835.16
Expenses5.535.245.124.774.90
EBITDA0.560.590.500.550.73
EBIT0.230.280.180.170.34
Profit Before Tax0.110.160.100.070.26
Net Profit0.010.050.150.020.01
Financial Ratios
Operating Profit Margin10.16%11.11%12.59%11.48%14.26%
Net Profit Margin0.18%0.94%3.78%0.42%0.20%
Earning Per Share (Diluted)0.010.100.300.040.02
Dividends Per Share0.000.000.000.000.00